Complement Deposits on Ocular Tissues Adjacent to Sites of Inflammation

REFERENCES

• Klein R J, Zeiss C, Chew E Y, Tsai J Y, Sackler R S, Haynes C, Henning A K, San Giovanni J P, Mane S M, Mayne S T, Bracken M B, Ferris F L, Ott J, Barnstable C, Hoh J. Complement factor H polymorphism in age-related macular degeneration. Science. 2005; 308: 385–389
   PubMed Web of Science ®Google Scholar
• Bora P S, Sohn J H, Cruz J M, Jha P, Nishihori H, Wang Y, Kaliappan S, Kaplan H J, Bora N S. Role of complement membrane attack complex in laser-induced choroidal neovascularization. J. Immunol. 2005; 174: 491–497
   PubMed Web of Science ®Google Scholar
• Jha P, Sohn J H, Xu Q, Nishihori H, Wang Y, Nishihori S, Manickam B, Kaplan H J, Bora P S, Bora N S. The complement system plays a critical role in the development of experimental autoimmune anterior uveitis. Invest. Ophthalmol. Vis. Sci. 2006; 47: 1030–1038
   PubMed Web of Science ®Google Scholar
• Nozaki M, Raisler B, Sakurai E, Sarma J V, Barnum S R, Lambris J D, Chen Y, Zhang K, Ambati B K, Baffi J Z, Ambati J. Drusen complement components C3a and C5a promote choroidal neovascularization. Proc. Natl. Acad. Sci. 2006; 103: 2328–2333
   PubMed Web of Science ®Google Scholar
• Stasi K, Nagel D, Yang X, Wang R F, Ren L, Podos S M, Mittag T, Danias J. Complement component 1Q (C1Q) upregulation in retina of murine, primate, and human glaucomatous eyes. Invest. Ophthalmol. Vis. Sci. 2006; 47: 1024–1029
   PubMed Web of Science ®Google Scholar
• Edwards A O, Ritter R, Abel K J, Manning A, Panhuysen C, Farrer L A. Complement factor H polymorphism and age-related macular degeneration. Science 2005; 308: 421–424
   PubMed Web of Science ®Google Scholar
• Hageman G S, Anderson D H, Johnson L V, Hancox L S, Taiber A J, Hardisty L I, Hageman J L, Stockman H A, Borchardt J D, Gehrs K M, Smith R J, Silvestri G, Russel S R, Klaver C C, Barbazetto I, Chang S, Yannuzzi L A, Barile G R, Merriam J C, Smith R T, Olsh A K, Bergeron J, Zernant J, Merriam J E, Gold B, Dean M, Allikmets R. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc. Natl. Acad. Sci. 2005; 102: 7227–7232
   PubMed Web of Science ®Google Scholar
• Jakobsdottir J, Conley Y P, Weeks D E, Mah T S, Ferrell R E, Gorin M B. Susceptibility genes for age-related maculopathy on chromosome 10q26. Am. J. Hum. Genet. 2005; 77: 389–407
   PubMed Web of Science ®Google Scholar
• Gold B, Merriam J E, Zernant J, Hancox L S, Taiber A J, Gehrs K, Cramer K, Neel J, Bergeron J, Barile G R, Smith R T, AMD Genetics Clinical Study Group, Hageman G S, Dean M, Allikmets R. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat. Genet. 2006; 38: 458–462
   PubMed Web of Science ®Google Scholar
• Gerl V B, Bohl J, Pitz S, Stoffelns B, Pfeiffer N, Bhakdi S. Extensive deposits of complement C3d and C5b-9 in the choriocapillaris of eyes of patients with diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 2002; 43: 1104–1108
   PubMed Web of Science ®Google Scholar
• Adamus G, Chan C C. Experimental autoimmune uveitides: multiple antigens, diverse diseases. Int. Rev. Immunol. 2002; 21: 209–229
   PubMedGoogle Scholar
• Takase H, Yu C R, Ham D I, Chan C C, Chen J, Vistica B P, Wawrousek E F, Durum S K, Egwuagu C E, Gery I. Inflammatory processes triggered by TCR engagement or by local cytokine expression: differences in profiles of gene expression and infiltrating cell populations. J. Leukoc. Biol. 2006; 80: 538–545
   PubMed Web of Science ®Google Scholar
• Goldback-Mansky R, Dailey N J, Canna S W, Gelabert A, Jones J, Rubin B I, Kim H J, Brewer C, Zalewski C, Wiggs E, Hill S, Turner M L, Karp B I, Aksentijevich I, Pucino F, Penzak S R, Haverkamp M H, Stein L, Adams B S, Moore T L, Fuhlbrigge B C, Shaham B, Jarvis J N, O'Neil K, Vehe R K, Beitz L O, Gardner G, Hannan W P, Warren R W, Horn W, Cole J L, Paul S M, Hawkins P N, Pham T H, Snyder C, Wesley R A, Hoffmann S C, Holland S M, Butman J A, Kastner D L. Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N. Engl. J. Med 2006; 355: 581–592
   PubMed Web of Science ®Google Scholar
• Wenzel A, Grimm C, Samardzija M, Reme C E. Molecular mechanisms of light-induced photoreceptor apoptosis and neuroprotection for retinal degeneration. Prog. Retin. Eye Res. 2005; 24: 275–306
   PubMed Web of Science ®Google Scholar
• Zhang C, Shen J, Lam T T, Zeng H, Chiang S K, Yang F, Tso M OM. Activation of microglia and chemokines in light-induced retinal degeneration. Mol. Vis. 2005; 11: 887–895
   PubMed Web of Science ®Google Scholar
• Zhang M, Chan C C, Vistica B, Hung V, Wiggert B, Gery I. Copolymer 1 inhibits experimental autoimmune uveoretinitis. J. Neuroimmunol. 2000; 103: 189–194
   PubMed Web of Science ®Google Scholar
• Lai J C, Fukushima A, Wawrousek E F, Lobanoff M C, Charukamnoetkanok P, Smith-Gill S J, Vistica B P, Lee R S, Egwuagu C E, Whitcup S M, Gery I. Immunotolerance against foreign antigen transgenically expressed in the lens. Invest. Ophthalmol. Vis. Sci. 1998; 39: 2049–2057
   PubMed Web of Science ®Google Scholar
• Korf H W, Oksche A, Ekstrom P, Gery I, Zigler J S, Jr., Klein D C. Pineoalocyte projections into the mammalian brain revealed with S-antigen antiserum. Science. 1986; 231: 735–737
   PubMed Web of Science ®Google Scholar
• Takase H, Yu C-R, Liu X, Fujimoto C, Gery I, Egwuagu C E. Induction of suppressors of cytokine signaling (SOCS) in the retina during experimental autoimmune uveitis (EAU): Potential neuroprotective role of SOCS proteins. J. Neuroimmunol. 2005; 168: 118–127
   PubMed Web of Science ®Google Scholar